Aerovate Therapeutics Company
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2019-01-01
Employees Number:
1-10
Funding Status:
IPO
Total Funding:
72600000
Last Funding Type:
Series A
Register and Claim Ownership